INS and metabolic dysfunction-associated steatotic liver disease: The results indicate that concurrent hesperidin administration and lifestyle modification improves risk factors linked to NAFLD, at least partially, by reducing activation of NF-κB and enhancing lipid profile and insulin sensitivity [98].